HIV-1 reverse transcriptase structure: function, inhibition, and resistance
HIV-1逆转录酶结构:功能、抑制和抵抗
基本信息
- 批准号:8416384
- 负责人:
- 金额:$ 67.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-01 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeActive SitesAnti-HIV AgentsAntiviral AgentsBindingBinding SitesBiochemicalBiologicalCatalysisCharacteristicsChemicalsChemistryClinicalCollaborationsCommitComplexCrystallizationCrystallographyDNADataDepositionDevelopmentDiphosphatesDrug DesignDrug TargetingDrug resistanceEngineeringEnzymesExcisionFingersFoscarnetFundingGenerationsGrantHIVHIV-1Human ResourcesImageryKnowledgeLaboratoriesLearningLigandsMethodologyMethodsMolecularMulti-Drug ResistanceMutationNNRTI-resistanceNucleic AcidsNucleosidesNucleotidesPatientsPharmaceutical PreparationsPolymeraseProductionPropertyProteinsPublicationsRNARNA-Directed DNA PolymeraseReactionReagentResearch PersonnelResistanceResolutionRetroviridaeReverse Transcriptase InhibitorsRibonuclease HSiteSpecificityStagingStructureTechnologyTransfer RNAUnited States National Institutes of HealthUniversitiesVariantViral PhysiologyWorkX ray diffraction analysisX-Ray CrystallographyX-Ray DiffractionZidovudine resistanceanalogbasechemical synthesiscomputer studiescrosslinkdesigndrug resistant virusimprovedinhibitor/antagonistiterative designmultidrug resistance inhibition therapymutantnon-nucleoside reverse transcriptase inhibitorsnovelpublic health relevanceresistance mutationscreeningsuccess
项目摘要
DESCRIPTION (provided by applicant): HIV-1 reverse transcriptase (RT) is a central target for antiviral treatment of AIDS and detailed knowledge of its structure and function has important clinical and biological consequences. Both nucleoside and non-nucleoside RT inhibitors are used as effective drugs for treating AIDS, but success can be limited by the emergence of drug-resistant viral variants. Novel non-nucleoside RT inhibitors have been developed through structure-based methods, including the recently approved drug etravirine/TMC125/Intelence, and we propose to carry out crystallographic studies that could enable structure-guided improvement of additional classes of RT inhibitors. The proposed work will involve structure determination of wild-type and drug-resistant HIV-1 RT in the presence and absence of nucleic acid substrates and inhibitors. Structural studies of inhibitor will explore binding sites for known drugs (NRTIs and NNRTIs) as well as other potential drug targeting sites including the RNase H active site. Use of strategically modified protein and nucleic acids will enhance the efficiency and quality of the structural studies. The structures determined will enhance our understanding of mechanisms of polymerase and RNase H catalysis, inhibition, and of drug resistance.
描述(由申请人提供):HIV-1逆转录酶(RT)是艾滋病抗病毒治疗的中心靶点,对其结构和功能的详细了解具有重要的临床和生物学意义。核苷类和非核苷类逆转录酶抑制剂都被用作治疗艾滋病的有效药物,但耐药病毒变异体的出现可能会限制其成功。通过基于结构的方法开发了新型非核苷类RT抑制剂,包括最近批准的药物etravirine/TMC 125/Intelence,我们建议进行晶体学研究,以实现结构指导的其他类别的RT抑制剂的改进。拟议的工作将涉及在存在和不存在核酸底物和抑制剂的情况下确定野生型和耐药HIV-1 RT的结构。抑制剂的结构研究将探索已知药物(NRTI和NNRTI)的结合位点以及其他潜在的药物靶向位点,包括RNase H活性位点。使用策略性修饰的蛋白质和核酸将提高结构研究的效率和质量。所确定的结构将增强我们对聚合酶和RNase H催化、抑制和耐药性机制的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD ARNOLD其他文献
EDWARD ARNOLD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD ARNOLD', 18)}}的其他基金
MACCHESS PROGRAM FOR AUTOMATION AND HIGH-THROUGHPUT
用于自动化和高吞吐量的 MACCHESS 程序
- 批准号:
8363513 - 财政年份:2011
- 资助金额:
$ 67.66万 - 项目类别:
STRUCTURAL STUDIES OF HIV-1 REVERSE TRANSCRIPTASE (RT)
HIV-1 逆转录酶 (RT) 的结构研究
- 批准号:
8170670 - 财政年份:2010
- 资助金额:
$ 67.66万 - 项目类别:
STRUCTURAL STUDIES OF HIV-1 RT AND RNAP
HIV-1 RT 和 RNAP 的结构研究
- 批准号:
8170617 - 财政年份:2010
- 资助金额:
$ 67.66万 - 项目类别:
MACCHESS PROGRAM FOR AUTOMATION AND HIGH-THROUGHPUT
用于自动化和高吞吐量的 MACCHESS 程序
- 批准号:
8171485 - 财政年份:2010
- 资助金额:
$ 67.66万 - 项目类别:
HIV-1 reverse transcriptase structure: function, inhibition, and resistance
HIV-1逆转录酶结构:功能、抑制和抵抗
- 批准号:
7750025 - 财政年份:2009
- 资助金额:
$ 67.66万 - 项目类别:
MACCHESS PROGRAM FOR AUTOMATION AND HIGH-THROUGHPUT
用于自动化和高吞吐量的 MACCHESS 程序
- 批准号:
7955572 - 财政年份:2009
- 资助金额:
$ 67.66万 - 项目类别:
STRUCTURAL STUDIES OF HIV-1 REVERSE TRANSCRIPTASE (RT)
HIV-1 逆转录酶 (RT) 的结构研究
- 批准号:
7957252 - 财政年份:2009
- 资助金额:
$ 67.66万 - 项目类别:
HIGH RES STRUCT OF HUMAN VIRUSES & VIRAL PROTEINS: SYNCH RADIATION AT CHESS: HIV
人类病毒的高分辨率结构
- 批准号:
7955535 - 财政年份:2009
- 资助金额:
$ 67.66万 - 项目类别:
相似海外基金
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 67.66万 - 项目类别:
Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 67.66万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 67.66万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 67.66万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 67.66万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 67.66万 - 项目类别:
Discovery Grants Program - Individual